With new funding awarded in 2024, the network will continue to deliver high quality initiatives that aim to positively impact the areas listed below.
- Equity of access to transformative therapies
- Improved NHS readiness for ATMP clinical trials
- Improved ATMP workforce efficiency
- The UK’s attractiveness to sponsors launching ATMP clinical trials
- Growth in the industry employment and investment in the UK
- Economic growth in levelling up priority locations in the UK
- Societal benefits from patients treated with ATMPs
- The number of ATMPs approved for use by NHS
Impact that the ATTC network has already delivered is highlighted below
- 1. Commercial growth and attractiveness
- 2. Engagement and collaboration
- 3. Leader in international standards and best practices
- 4. Clinical trials and patient access
- 5. Manufacturing, supply chain and logistics
- 6. Education and workforce